Board of Directors


Marc Barbeau, Groupe Laperrière & Verreault Inc.

Marc Barbeau, C.A. and Master in Taxation, was promoted in February 2007 as CFO at Groupe Laperrière & Verreault inc. (GL&V). He joined GL&V in 2000 as VP Treasury and in 2006 he became Assistant VP Financial Operations. Prior to GL&V, he was with the accounting firm Raymond Chabot Grant Thornton.

Dr. Jean -Pierre L. Bouchard, Hôpital de L'enfant Jésus

Dr. Jean-Pierre L. Bouchard, born in Baie-Saint-Paul, Charlevoix, studied medicine at Laval University in Quebec city and graduated as a specialist in neurology from the University of Toronto. In 1974, he identified for the first time the Ataxia of Charlevoix-Saguenay and other types of ataxia in Quebec. Dr. Bouchard is a professor at the medical faculty (neurology) at Laval University, director of the Cliniques des maladies neuromusculaires et de la sclérose en plaques ( Québec and Charlevoix) and vice-président of the Canadian Neurological Society Foundation. Recently, he has accepted the position of president of the Comité scientifique de l’inscription des médicaments (CSI) au Conseil du Médicament du Québec.

Michel A. Brunet, Fraser Milner Casgrain

Michel A. Brunet, Chair and Chief Executive Officer of Fraser Milner Casgrain LLP, has more than 30 years of experience in selling, acquiring and financing businesses.

Carl Deslongchamps, KPMG

Carl Deslongchamps, D.E.S.S. Fisc., is a Partner with the R&D and Strategic Relocation and Expansion Services (SRES) Groups in KPMG's Montreal office. He has a Bachelor of Commerce degree, with a Finance option, and a Diploma in Taxation. Before joining KPMG's team in September 2000, he held the position of Assistant Director, Tax Incentives Section in the Montreal Tax Services Office of the Canada Revenue Agency (CRA).

Maurice Fréchette, Power Corporation of Canada

Maurice Fréchette is Director / Taxation at Power Corporation since 1999. Prior to joining Power Corporation, he was director at ARC. He is a member of several organisations such as TEI, APFF, CTF, IFA and the Chambre de Commerce Montréal Métropolitain. Furthermore, he is on the Board of the APFF, the Fondation Gratien Gélinas, and on the Finances Committee of the Chambre de commerce Montréal Métropolitain.

Dr. Martin Godbout, Genome Canada

Dr. Martin Godbout holds a B.Sc. in biochemistry and a Ph.D. in physiology and molecular endocrinology from Laval University. From 1985 to 1990, he received a postdoctoral fellowship from the Medical Research Council (MRC) of Canada and was trained in Neuromolecular Biology at the Scripps Research Institute in California. Since April 1, 2000, Dr. Godbout has been the President and CEO of Genome Canada, a private, not-for-profit corporation, dedicated to investing and implementing a national strategy in genomics and proteomics research in Canada.

Jean Groleau, Fraser Milner Casgrain

Me Jean Groleau is a fiscal lawyer and partner at Fraser Milner Casgrain law firm. He is the co-founder and president of the Ataxia of Charlevoix-Saguenay Foundation. He is on the Board of Directors of the Sainte-Justine Hospital Foundation and president of the Donations Committee of Sainte-Justine Hospital. He is also president and member of the Association de Planification Fiscale et Financière (APFF).

Dr. Thomas J. Hudson, Ontario Institute for Cancer Research

A native of the Saguenay region, Dr. Hudson is one of Canada's top scientists. He studied medicine at the Université de Montréal and completed his post-doctorate studies at Boston's MIT and Whitehead Institute. Dr. Hudson lead Canada into a new era of genomics research while at Génome Québec. In July 2006, he was named President of the Ontario Institute for Cancer Research.

Dr. Jean Mathieu, Hôpital de Chicoutimi

Dr. Jean Mathieu, is a neurologist and medical director of the Saguenay-Lac-Saint-Jean neuromuscular clinic (Québec).

Jacques Marchand, National Bank of Canada

Jacques Marchand is General Manager, Corporate Financial Group at the National Bank of Canada. He has a bachelor degree from l'École des Hautes Études Commerciale and a MBA from the Université du Québec in Montréal. He is a member of the Board of Directors of the Horace Boivin Foundation.

Dr. Guy A. Rouleau, Centre de Recherche du CHU Ste-Justine

Born in Ottawa, Dr. Guy Rouleau graduated from the University of Ottawa with a medical degree in 1980 and spent the next five years pursuing training as a clinical specialist in neurology at McGill University in Montréal. Currently an Associate Professor at McGill University, he also directs the Molecular Neurogenetics Laboratory at the McGill University Centre for Research in Neurosciences. He is also research director at the CHU Ste Justine Research Centre.